Li, Y., Zhou, Y., Mao, F., Shen, S., Zhao, B., Xu, Y., . . . Sun, Q. (2020). miR-452 Reverses Abnormal Glycosylation Modification of ERα and Estrogen Resistance in TNBC (Triple-Negative Breast Cancer) Through Targeting UGT1A1. Front Oncol.
Citação norma ChicagoLi, Yan, et al. "MiR-452 Reverses Abnormal Glycosylation Modification of ERα and Estrogen Resistance in TNBC (Triple-Negative Breast Cancer) Through Targeting UGT1A1." Front Oncol 2020.
MLA引文Li, Yan, et al. "MiR-452 Reverses Abnormal Glycosylation Modification of ERα and Estrogen Resistance in TNBC (Triple-Negative Breast Cancer) Through Targeting UGT1A1." Front Oncol 2020.
警告：這些引文格式不一定是100％准確.